Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Deficit

v3.21.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Beginning balance at Nov. 30, 2019 $ (6,952,851) $ 135,989 $ 35,918,827 $ (20,563,357) $ (22,444,310)
Beginning balance, shares at Nov. 30, 2019   13,598,909      
Common stock issued 41,000 $ 347 40,653    
Common stock issued, shares   34,729      
Compensatory element of stock options 224,258   224,258    
Net income 686,966       686,966
Ending balance at Feb. 29, 2020 (6,000,627) $ 136,336 36,183,738 (20,563,357) (21,757,344)
Ending balance, shares at Feb. 29, 2020   13,633,638      
Beginning balance at Nov. 30, 2020 (2,665,135) $ 136,336 36,581,600 (20,563,357) (18,819,714)
Beginning balance, shares at Nov. 30, 2020   13,633,638      
Common stock issued 191,622 $ 253 191,369    
Common stock issued, shares   25,300      
Compensatory element of stock options 84,818   84,818    
Net income 693,590       693,590
Ending balance at Feb. 28, 2021 $ (1,695,105) $ 136,589 $ 36,857,787 $ (20,563,357) $ (18,126,124)
Ending balance, shares at Feb. 28, 2021   13,658,938